𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gamma-linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial

✍ Scribed by Robert B. Zurier; Ronald G. Rossetti; Eric W. Jacobson; Deborah M. Demarco; Nancy Y. Liu; Joseph E. Temming; Bernadette M. White; Michael Laposata


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
971 KB
Volume
39
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Treatment of rheumatoid arthritis with a
✍ Michael E. Weinblatt; Arthur Kavanaugh; Ruben Burgos-Vargas; Ara H. Dikranian; G πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 165 KB πŸ‘ 2 views

## Abstract ## Objective Spleen tyrosine kinase (Syk) has been identified as an important modulator of immune signaling in B cells and cells bearing Fcγ‐activating receptors. R788, a prodrug of active metabolite R406, has been shown to be an inhibitor of Syk kinase, active in a variety of in vitro

Efficacy of methotrexate treatment in pa
✍ Henrike van Dongen; Jill van Aken; Leroy R. Lard; Karen Visser; H. Karel Ronday; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex